Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report

Acta Clin Belg. 2005 Nov-Dec;60(6):329-37. doi: 10.1179/acb.2005.050.

Abstract

A multidisciplinary expert panel, appointed by the High Council for Public Health, evaluated the scientific evidence on which the recommendations for the appropriate use of the pneumococcal vaccine was based and reviewed the studies that became available since previous reports. The conclusions of the working group, presented in this manuscript, resulted in an update of the Belgian recommendations for pneumococcal vaccination.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Belgium
  • Cost-Benefit Analysis
  • Humans
  • Pneumococcal Infections / complications
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / administration & dosage*
  • Pneumococcal Vaccines / economics
  • Practice Guidelines as Topic
  • Treatment Outcome

Substances

  • 23-valent pneumococcal capsular polysaccharide vaccine
  • Pneumococcal Vaccines